MOMENTA PHARMACEUTICALS INC·4

Feb 11, 7:00 PM ET

Cieplinska Agnieszka 4

4 · MOMENTA PHARMACEUTICALS INC · Filed Feb 11, 2020

Insider Transaction Report

Form 4
Period: 2020-02-07
Cieplinska Agnieszka
Chief Accounting Officer (PAO)
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-02-07+16,31316,313 total
    Exercise: $31.87Exp: 2030-02-07Common Stock (16,313 underlying)
  • Award

    Restricted Stock Units

    2020-02-07+8,1938,193 total
    Common Stock (8,193 underlying)
Footnotes (5)
  • [F1]Each Restricted Stock Unit represents a contingent right to receive one share of MNTA common stock.
  • [F2]Represents restricted stock units granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan, as amended and restated.
  • [F3]Subject to the officer continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
  • [F4]Represents options granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan, as amended and restated.
  • [F5]Subject to certain criteria, the stock option will vest and become exercisable with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -